Early-stage squamous cell carcinoma of the esophagus is primarily treated with endoscopic resection, while esophagectomy or chemoradiotherapy may be considered for select patients based on staging and ...
Central Screening enhances trial enrollment by integrating technology and expert oversight, streamlining the process for community oncology practices. The system utilizes Genospace to match patient ...
Shane Dormady, MD, discusses the unique emotional care needs of young adults with cancer, emphasizing hope and holistic support for better outcomes. Cancer care for younger adults emphasizes emotional ...
Subcutaneous daratumumab with lenalidomide significantly increased MRD-negative conversion rates compared to lenalidomide alone in multiple myeloma patients post-transplant. The combination therapy ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...
David Chism, MD: For pairing it with the immunotherapy, I would prefer just 1 chemotherapy rather than ...
Cancer care for younger adults emphasizes emotional well-being and multidisciplinary support, transforming treatment ...
The FDA has approved the Guardant 360 CDx as a companion diagnostic to identify ESR1 mutation in patients with advanced breast cancer who may benefit from treatment with imlunestrant (Inluriyo). 1 ...
In an interview with Targeted Oncology, Shane Dormady, MD, medical director of El Camino Health Cancer Center, highlights the unique challenges and differences in the priorities o ...
Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...
An expert discusses the MARIPOSA study’s impact on managing central nervous system (CNS) involvement in EGFR-mutated non–small cell lung cancer, emphasizing improved brain progression-free survival, ...